Want to see AU:AGN full AI Analyst Report?
Argenica Therapeutics Ltd (AGN) Income Statement
Argenica Therapeutics Ltd Income Statement
Last quarter (Q4 2026), Argenica Therapeutics Ltd's total revenue was $0.00, a decrease of 100.00% from the same quarter last year. In Q4, Argenica Therapeutics Ltd's net income was $2.45M. See Argenica Therapeutics Ltd’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 |
|---|---|---|---|---|---|
| $ 0.00 | $ 3.21M | $ 2.60M | $ 1.75M | $ 259.10K | |
| $ 0.00 | $ 3.21M | $ 2.60M | $ 1.75M | $ 259.10K | |
| $ 7.06M | $ 10.90M | $ 8.27M | $ 6.62M | $ 4.35M | |
| Depreciation and Amortization | $ 0.00 | $ 7.68M | $ 5.67M | $ 4.87M | $ 4.09M |
| $ -7.06M | $ 0.00 | $ -1.90M | $ -1.32M | $ -257.41K | |
| $ -7.06M | $ -7.68M | $ -5.67M | $ -6.62M | $ -4.09M | |
| $ 1.72M | $ 512.25K | $ -1.90M | $ 431.93K | $ 1.68K | |
| $ -5.34M | $ -7.17M | $ -7.57M | $ -6.19M | $ -4.09M | |
| $ -1.37M | $ -7.17M | $ -5.48M | $ -4.82M | $ -4.09M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.01 | $ -0.06 | $ -0.05 | $ -0.06 | $ -0.06 |
| Diluted EPS | $ -0.01 | $ -0.06 | $ -0.05 | $ -0.06 | $ -0.06 |
| Weighted Average Shares Outstanding | 128.46M | 127.53M | 103.39M | 87.58M | 73.93M |
| Weighted Average Shares Outstanding (Diluted) | 128.46M | 127.53M | 103.71M | 87.58M | 73.93M |
Currency in AUD
